{{Drugbox
| Watchedfields = changed
| verifiedrevid = 443481594
| IUPAC_name = (''RS'')-3-(4-phenylpiperazin-1-yl)propane-1,2-diol
| image = Dropropizine.png

<!--Clinical data-->
| tradename =  
| Drugs.com = {{drugs.com|international|dropropizine}}
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = <!--             / Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL         / P       / POM / CD / Class A, B, C -->
| legal_US = <!-- OTC                   / Rx-only  / Schedule I, II, III, IV, V -->
| legal_status =  
| routes_of_administration =  

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  

<!--Identifiers-->
| CAS_number = 17692-31-8
| ATC_prefix = R05
| ATC_suffix = DB19
| PubChem = 3169
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 3057
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = U0K8WHL37U
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D07393
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 151445

<!--Chemical data-->
| C=13 | H=20 | N=2 | O=2 
| molecular_weight = 236.31 g/mol
| smiles = OC(CN2CCN(c1ccccc1)CC2)CO
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C13H20N2O2/c16-11-13(17)10-14-6-8-15(9-7-14)12-4-2-1-3-5-12/h1-5,13,16-17H,6-11H2
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = PTVWPYVOOKLBCG-UHFFFAOYSA-N
}}

'''Dropropizine''' (or '''dipropizine''') is a [[cough suppressant]].<ref>{{Cite journal 
| last1 = De Blasio | first1 = F. 
| last2 = Dicpinigaitis | first2 = P. V. 
| last3 = Rubin | first3 = B. K. 
| last4 = De Danieli | first4 = G. 
| last5 = Lanata | first5 = L. 
| last6 = Zanasi | first6 = A. 
| doi = 10.1186/1745-9974-8-1 
| title = An observational study on cough in children: Epidemiology, impact on quality of sleep and treatment outcome 
| journal = Cough 
| volume = 8 
| issue = 1 
| pages = 1 
| year = 2012 
| pmid = 22269875 
| pmc =3274450 
}}</ref>

* Commercialized in African countries, in Congo for instance.

==See also==

* [[Levodropropizine]]

==References==
{{reflist}}

{{Cough and cold preparations}}
{{Piperazines}}

[[Category:Antitussives]]
[[Category:Piperazines]]
[[Category:Vicinal diols]]


{{respiratory-system-drug-stub}}